Confusion in the Study of Immune Reconstitution Inflammatory Syndrome
Article Sidebar
Main Article Content
Abstract
As a consequence of late presentation for HIV care, a significant proportion of individuals develop immune reconstitution inflammatory syndrome (IRIS) soon after initiation of antiretroviral therapy. Incidence, predictors, and models of pathogenesis of IRIS vary in the literature. Here we discuss factors that may contribute to this lack of consensus. We propose that different pathogens drive different types of IRIS and suggest that these clinical conditions should be studied individually and not grouped under the general heading of “IRIS.”
Downloads
Article Details
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133(6):447-54. PubMed PMID: 10975963.
2. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, IEDEA Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251-61. PubMed PMID: 20334848. PubMed Central PMCID: 4183458. doi: 10.1016/S1473-3099(10)70026-8
3. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, Price P, Flexman JP, Tay-Kearney ML. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1(2):107-15. PubMed PMID: 11737333.
4. Conesa-Botella A, Loembe MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R, Group TI. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr. 2011;58(5):463-8. PubMed PMID: 21963941. doi: 10.1097/QAI.0b013e31823801de
5. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19(4):399-406. PubMed PMID: 15750393.
6. Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, Eron J, Sanne I, Powderly W, Hogg E, Suckow C, Zolopa A. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One. 2010;5(7):e11416. PubMed PMID: 20617176. PubMed Central PMCID: 2895658. doi: 10.1371/journal.pone.0011416
7. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18(12):1615-27. PubMed PMID: 15280772.
8. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42(11):1639-46. PubMed PMID: 16652323. doi 10.1086/503903
9. Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol. 2004;6(5):423-33. PubMed PMID: 15056213. doi: 10.1111/j.1462-5822.2004.00371.x
10. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322):112-6. PubMed PMID: 9204894.
11. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, Gicquel B, Vicaut E, Lagrange PH, Sereni D, Autran B. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS. 2006;20(2):F1-7. PubMed PMID: 16511406. doi: 10.1097/01.aids.0000202648.18526.bf
12. Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Seldon R, Chegou NN, Maartens G, Rangaka MX, Rebe K, Walzl G, Wilkinson RJ. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J. 2011;37(5):1248-59. PubMed PMID: 20817712. PubMed Central PMCID: 3242045. doi: 10.1183/09031936.00091010
13. Tadokera R, Wilkinson KA, Meintjes GA, Skolimowska KH, Matthews K, Seldon R, Rangaka MX, Maartens G, Wilkinson RJ. Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis. J Infect Dis. 2013;207(7):1148-56. PubMed PMID: 23303806. PubMed Central PMCID: 3583273. doi: 10.1093/infdis/jit002
14. Tan HY, Yong YK, Andrade BB, Shankar EM, Ponnampalavanar S, Omar SF, Narendran G, Kamarulzaman A, Swaminathan S, Sereti I, Crowe SM, French MA. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2015;29(4):421-31. PubMed PMID: 25565499. doi: 10.1097/QAD.0000000000000557
15. Vignesh R, Kumarasamy N, Lim A, Solomon S, Murugavel KG, Balakrishnan P, Solomon SS, Mayer KH, Swathirajan CR, Chandrasekaran E, Pradeep A, Poongulali S, Benson CA, French MA. TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens. J Acquir Immune Defic Syndr. 2013;64(3):241-8. PubMed PMID: 23774879. doi: 10.1097/QAI.0b013e31829f6df2
16. Mahnke YD, Greenwald JH, DerSimonian R, Roby G, Antonelli LR, Sher A, Roederer M, Sereti I. Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. Blood. 2012;119(13):3105-12. PubMed PMID: 22219223. PubMed Central PMCID: 3321870. doi: 10.1182/blood-2011-09-380840
17. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5(6):361-73. PubMed PMID: 15919622. doi: 10.1016/S1473-3099(05)70140-7
18. Tran HT, Van den Bergh R, Vu TN, Laukens K, Worodria W, Loembe MM, Colebunders R, Kestens L, De Baetselier P, Raes G, Group T-IS. The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome. Immunobiology. 2014;219(1):37-44. PubMed PMID: 23958034. doi: 10.1016/j.imbio.2013.07.004
19. Andrade BB, Singh A, Narendran G, Schechter ME, Nayak K, Subramanian S, Anbalagan S, Jensen SM, Porter BO, Antonelli LR, Wilkinson KA, Wilkinson RJ, Meintjes G, van der Plas H, Follmann D, Barber DL, Swaminathan S, Sher A, Sereti I. Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome. PLoS Pathog. 2014;10(10):e1004433. PubMed PMID: 25275318. PubMed Central PMCID: 4183698. doi: 10.1371/journal.ppat.1004433
20. Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Nfanyana K, Bellamy SL, MacGregor RR, Gross R, Weissman D, Bisson GP. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. Lancet Infect Dis. 2015;15(4):429-38. PubMed PMID: 25672566. PubMed Central PMCID: 4624391. doi: 10.1016/S1473-3099(15)70008-3
21. Tan HY, Yong YK, Shankar EM, Paukovics G, Ellegard R, Larsson M, Kamarulzaman A, French MA, Crowe SM. Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. J Immunol. 2016;196(10):4052-63. PubMed PMID: 27076678. doi: 10.4049/jimmunol.1502203
22. Wilkinson KA, Walker NF, Meintjes G, Deffur A, Nicol MP, Skolimowska KH, Matthews K, Tadokera R, Seldon R, Maartens G, Rangaka MX, Besra GS, Wilkinson RJ. Cytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome. J Immunol. 2015;194(4):1748-54. PubMed PMID: 25589068. PubMed Central PMCID: 4319311. doi: 10.4049/jimmunol.1402105
23. Pean P, Nerrienet E, Madec Y, Borand L, Laureillard D, Fernandez M, Marcy O, Sarin C, Phon K, Taylor S, Pancino G, Barre-Sinoussi F, Scott-Algara D, Cambodian Early versus Late Introduction of Antiretroviral Drugs (CAMELIA) Study Team. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood. 2012;119(14):3315-20. PubMed PMID: 22343919. doi: 10.1182/blood-2011-09-377523
24. Marais S, Meintjes G, Pepper DJ, Dodd LE, Schutz C, Ismail Z, Wilkinson KA, Wilkinson RJ. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2013;56(3):450-60. PubMed PMID: 23097584. PubMed Central PMCID: 3540040. doi: 10.1093/cid/cis899
25. Marais S, Wilkinson KA, Lesosky M, Coussens AK, Deffur A, Pepper DJ, Schutz C, Ismail Z, Meintjes G, Wilkinson RJ. Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2014;59(11):1638-47. PubMed PMID: 25107295. PubMed Central PMCID: 4227574. doi: 10.1093/cid/ciu641
26. Barber DL, Andrade BB, Sereti I, Sher A. Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol. 2012;10(2):150-6. PubMed PMID: 22230950. PubMed Central PMCID: 3507517. doi: 10.1038/nrmicro2712
27. Meintjes G, Wilkinson RJ, Morroni C, Pepper DJ, Rebe K, Rangaka MX, Oni T, Maartens G. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2010;24(15):2381-90. PubMed PMID: 20808204. PubMed Central PMCID: 2940061. doi: 10.1097/QAD.0b013e32833dfc68
28. Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Tadokera R, Conesa-Botella A, Seldon R, Rangaka MX, Rebe K, Pepper DJ, Morroni C, Colebunders R, Maartens G, Wilkinson RJ. Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med. 2012;186(4):369-77. PubMed PMID: 22700860. PubMed Central PMCID: 3443811. doi: 10.1164/rccm.201201-0094OC
29. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S. Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis. 2002;2(5):281-92. PubMed PMID: 12062994.
30. Connick E, Kane MA, White IE, Ryder J, Campbell TB. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin Infect Dis. 2004;39(12):1852-5. PubMed PMID: 15578411. doi: 10.1086/426078
31. Aoki Y, Tosato G. Interactions between HIV-1 Tat and KSHV. Curr Top Microbiol Immunol. 2007;312:309-26. PubMed PMID: 17089803.
32. Toschi E, Bacigalupo I, Strippoli R, Chiozzini C, Cereseto A, Falchi M, Nappi F, Sgadari C, Barillari G, Mainiero F, Ensoli B. HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol Biol Cell. 2006;17(4):1985-94. PubMed PMID: 16436505. PubMed Central PMCID: 1415297. doi: 10.1091/mbc.E05-08-0717
33. Feller L, Lemmer J. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer. 2008;3:1. PubMed PMID: 18208585. PubMed Central PMCID: 2265259. doi: 10.1186/1750-9378-3-1
34. Hyun TS, Subramanian C, Cotter MA 2nd, Thomas RA, Robertson ES. Latency-associated nuclear antigen encoded by Kaposi’s sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells. J Virol. 2001;75(18):8761-71. PubMed PMID: 11507221. PubMed Central PMCID: 115121. doi: 10.1128/JVI.75.18.8761-8771.2001
35. Sun Q, Matta H, Chaudhary PM. Kaposi’s sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat. Retrovirology. 2005;2:9. PubMed PMID: 15713234. PubMed Central PMCID: 554086. doi: 10.1186/1742-4690-2-9
36. Letang E, Lewis JJ, Bower M, Mosam A, Borok M, Campbell TB, Naniche D, Newsom-Davis T, Shaik F, Fiorillo S, Miro JM, Schellenberg D, Easterbrook PJ. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK. AIDS. 2013;27(10):1603-13. PubMed PMID: 23462220. doi: 10.1097/QAD.0b013e328360a5a1
37. Ablanedo-Terrazas Y, Alvarado-de la Barrera C, Ormsby CE, Ruiz-Cruz M, Reyes-Teran G. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi’s sarcoma in the upper airway. Laryngoscope. 2015;125(4):E132-7. PubMed PMID: 25345840. doi: 10.1002/lary.24988
38. Letang E, Almeida JM, Miro JM, Ayala E, White IE, Carrilho C, Bastos R, Nhampossa T, Menendez C, Campbell TB, Alonso PL, Naniche D. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J Acquir Immune Defic Syndr. 2010;53(5):589-97. PubMed PMID: 19801945. doi: 10.1097/QAI.0b013e3181bc476f
39. Fernandez-Sanchez M, Iglesias MC, Ablanedo-Terrazas Y, Ormsby CE, Alvarado-de la Barrera C, Reyes-Teran G. Steroids are a risk factor for Kaposi’s sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection. AIDS. 2016;30(6):909-14. PubMed PMID: 26636923. PubMed Central PMCID: 4794188. doi: 10.1097/QAD.0000000000000993
40. Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA. Kaposi’s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell. 2003;3(2):131-43. PubMed PMID: 12620408.
41. Schulhafer EP, Grossman ME, Fagin G, Bell KE. Steroid-induced Kaposi’s sarcoma in a patient with pre-AIDS. Am J Med. 1987;82(2):313-7. PubMed PMID: 3812527.
42. Real FX, Krown SE, Koziner B. Steroid-related development of Kaposi’s sarcoma in a homosexual man with Burkitt’s lymphoma. Am J Med. 1986;80(1):119-22. PubMed PMID: 3942143.
43. Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110(11):937-40. PubMed PMID: 2719427.
44. Volkow PF, Cornejo P, Zinser JW, Ormsby CE, Reyes-Teran G. Life-threatening exacerbation of Kaposi’s sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome. AIDS. 2008;22(5):663-5. PubMed PMID: 18317012. doi: 10.1097/QAD.0b013e3282f4f223
45. Valencia ME, Piedrafita V, Del Val D, Corcuera MT. Aggressive Kaposi’s sarcoma related to corticosteroids or immune reconstitution syndrome? Rev Clin Esp. 2011;211(6):321-2. PubMed PMID: 21492846. ¿Sarcoma de Kaposi agresivo asociado a la administracion de esteroides o sindrome de reconstitucion inmune? doi: 10.1016/j.rce.2010.11.017
46. Englert D, Seal P, Parsons C, Arbour A, Roberts E, 3rd, Lopez FA. Clinical case of the month: a 22-year-old man with AIDS presenting with shortness of breath and an oral lesion. J La State Med Soc. 2014;166(5):224-30. PubMed PMID: 25369228.
47. Guo WX, Antakly T. AIDS-related Kaposi’s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol. 1995;146(3):727-34. PubMed PMID: 7887453. PubMed Central PMCID: 1869167.
48. Hudnall SD, Rady PL, Tyring SK, Fish JC. Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro. Transplantation. 1999;67(5):648-52. PubMed PMID: 10096517.
49. Murakami-Mori K, Mori S, Taga T, Kishimoto T, Nakamura S. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi’s sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi’s sarcoma cell proliferation. J Immunol. 1997;158(11):5518-26. PubMed PMID: 9164976.
50. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. Glucocorticoids induce Kaposi’s sarcoma cell proliferation through the regulation of transforming growth factor-beta. Blood. 1997;89(5):1491-500. PubMed PMID: 9057628.
51. Togi S, Nakasuji M, Muromoto R, Ikeda O, Okabe K, Kitai Y, Kon S, Oritani K, Matsuda T. Kaposi’s sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities. Biochem Biophys Res Commun. 2015;463(3):395-400. PubMed PMID: 26032496. doi: 10.1016/j.bbrc.2015.05.080
52. Martin-Blondel G, Cuzin L, Delobel P, Cuvinciuc V, Dumas H, Alvarez M, Massip P, Marchou B. Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? AIDS. 2009;23(18):2545-6. PubMed PMID: 19907215. doi: 10.1097/QAD.0b013e32833365f4
53. Sierra-Madero JG, Ellenberg SS, Rassool MS, Tierney A, Belaunzaran-Zamudio PF, Lopez-Martinez A, Pineirua-Menendez A, Montaner LJ, Azzoni L, Benitez CR, Sereti I, Andrade-Villanueva J, Mosqueda-Gomez JL, Rodriguez B, Sanne I, Lederman MM, CADIRIS study team. Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. Lancet HIV. 2014;1(2):e60-7. PubMed PMID: 26423989. doi: 10.1016/S2352-3018(14)70027-X
54. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, van der Loeff MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R, International Network for the Study of HIVaI. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516-23. PubMed PMID: 18652998. PubMed Central PMCID: 2804035. doi: 10.1016/S1473-3099(08)70184-1
55. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR, International Network for the Study of HIVaI. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791-802. PubMed PMID: 21029993. PubMed Central PMCID: 3026057. doi: 10.1016/S1473-3099(10)70170-5
56. Letang E, Naniche D, Bower M, Miro JM. Kaposi sarcoma-associated immune reconstitution inflammatory syndrome: in need of a specific case definition. Clin Infect Dis. 2012;55(1):157-8; author reply 8-9. PubMed PMID: 22491336. doi: 10.1093/cid/cis308
57. Ruiz-Cruz M, Alvarado-de la Barrera C, Ablanedo-Terrazas Y, Reyes-Teran G. Proposed clinical case definition for cytomegalovirus-immune recovery retinitis. Clin Infect Dis. 2014;59(2):298-303. PubMed PMID: 24771331. doi: 10.1093/cid/ciu291
58. Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Tadokera R, Conesa-Botella A, Seldon R, Rangaka MX, Rebe K, Pepper DJ, Morroni C, Colebunders R, Maartens G, Wilkinson RJ. Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med. 2012;186(4):369-77. PubMed PMID: 22700860. PubMed Central PMCID: 3443811. doi: 10.1164/rccm.201201-0094OC
59. Donald PR, Schoeman JF, Beyers N, Nel ED, Carlini SM, Olsen KD, McCracken GH. Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis. 1995;21(4):924-9. PubMed PMID: 8645841.